Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john.d who wrote (6901)	3/7/2001 9:03:04 PM
From: Mark Bartlett	Read Replies (2) of 14101

john, <<I suspect it might be the part were Kuhne mentions that they are going to show the unblinded results to the FDA.>> Maybe I am the one blinded, but the only reference I see, regarding showing the FDA any data is: *A blinded* interim analysis of this trial will be conducted soon and presented to the FDA** Is there something I missed, because the copy I have says BLINDED? I am not trying to be funny here, I really am asking if I missed something in the PR. Assuming I did not, showing the FDA a blinded interim study would, IMO, only be done if there were two very clear and distinct groups emerging in the trial. I personally believe that to be the case. If I missed something, please let me know. Best to all, Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next